XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.21.1

EMPLOYEE STOCK COMPENSATION | 3 Months Ended
--- | ---
Mar. 31, 2021
Share-based Payment Arrangement [Abstract] |
EMPLOYEE STOCK COMPENSATION | EMPLOYEE STOCK COMPENSATION On May 31, 2018, our stockholders approved the Company's 2018 Omnibus Stock Incentive Plan (“2018 Omnibus Plan”). The 2018 Omnibus Plan provides that the maximum number of shares available for awards is 4,417,882. As of March 31, 2021, 3,183,000 shares were available for future awards. Stock-based Compensation Expense The following table presents stock-based compensation expense and the related tax benefits for the periods indicated:
|  | Three Months Ended March 31, |  |
($ in thousands) |  | 2021 |  | 2020 |  |  |  |
Stock options |  | $ | — |  |  | $ | 2 |  |  |  |  |
Restricted stock awards and units |  | 1,544 |  |  | 1,574 |  |  |  |  |
Total share-based compensation expense |  | $ | 1,544 |  |  | $ | 1,576 |  |  |  |  |
Related tax benefits |  | $ | 455 |  |  | $ | 464 |  |  |  |  |
The following table presents unrecognized stock-based compensation expense as of March 31, 2021:
($ in thousands) |  | Unrecognized Expense |  | Weighted-Average Remaining Expected Recognition Period
Restricted stock awards and restricted stock units |  | $ | 8,861 |  |  | 2.5 years
Total |  | $ | 8,861 |  |  | 2.5 years
Stock Options We issued stock options to certain employees, officers, and directors. Stock options are issued at the closing market price immediately before the grant date and generally have a three to five year vesting period and contractual terms of seven to ten years. We recognize an income tax deduction upon exercise of a stock option to the extent taxable income is recognized by the option holder. In the case of a non-qualified stock option, the option holder recognizes taxable income based on the fair market value of the shares acquired at the time of exercise less the exercise price. The following table represents stock option activity for the three months ended March 31, 2021:
|  | Three Months Ended March 31, 2021
($ in thousands except per share data) |  | Number of Shares |  | Weighted-Average Exercise Price Per Share |  | Weighted-Average Remaining Contract Term |  | Aggregated Intrinsic Value
Outstanding at beginning of period |  | 55,069 |  |  | $ | 13.96 |  |  |  |  |
Exercised |  | (40,165) |  |  | $ | 14.30 |  |  |  |  |
Outstanding at end of period |  | 14,904 |  |  | $ | 13.05 |  |  | 4.0 years |  | $ | 75 |
Exercisable at end of period |  | 14,904 |  |  | $ | 13.05 |  |  | 4.0 years |  | $ | 75 |
There were no unvested stock options as of March 31, 2021 and December 31, 2020. Restricted Stock Awards and Restricted Stock Units We also have granted restricted stock awards and restricted stock units to certain employees, officers, and directors. The restricted stock awards and units are valued at the closing price of our stock on the measurement date. The restricted stock awards and units fully vest after a specified period (generally ranging from one to five years) of continued service from the date of grant plus, in some cases, the satisfaction of performance conditions. These performance targets include conditions relating to our profitability and regulatory standing. The actual amounts of stock released upon vesting will be determined by the Compensation Committee of our Board of Directors upon the Committee's certification of the satisfaction of the target level of performance. We recognize an income tax deduction in an amount equal to the taxable income reported by the holders of the restricted stock, generally upon vesting or, in the case of restricted stock units, when settled. The following table presents unvested restricted stock awards and restricted stock units activity for the three months ended March 31, 2021:
|  | Three Months Ended March 31, 2021 |  |
|  | Number of Shares |  | Weighted Average Grant Date Fair Value Per Share |  |  |  |
Outstanding at beginning of period |  | 848,302 |  |  | $ | 14.42 |  |  |  |  |
Granted (1) |  | 220,457 |  |  | $ | 20.63 |  |  |  |  |
Vested (2) |  | (152,248) |  |  | $ | 14.82 |  |  |  |  |
Forfeited (3) |  | (50,532) |  |  | $ | 11.17 |  |  |  |  |
Outstanding at end of period |  | 865,979 |  |  | $ | 16.12 |  |  |  |  |
(1)There were 58,839 performance-based shares/units included in shares granted for the three months ended March 31, 2021. (2)There were 69,109 performance-based shares/units included in vested shares for the three months ended March 31, 2021. (3)The number of forfeited shares includes aggregate performance-based shares/units of 40,160 for the three months ended March 31, 2021. Stock Appreciation Rights On August 21, 2012, we granted to the then, and now former, chief executive officer, a ten-year stock appreciation right (“SAR”), which were fully exercised during the three months ended March 31, 2021, resulting in the issuance of 305,772 shares of voting common stock. In connection with the exercise of the SARs, we recognized a tax benefit of $2.1 million (refer to Note 8 - Income Taxes). The following table represents SARs activity and the weighted average exercise price per share as of and for the three months ended March 31, 2021:
|  | Three Months Ended March 31, 2021
($ in thousands except per share data) |  | Number of Shares |  | Weighted-Average Exercise Price Per Share |  |  |  |
Outstanding at beginning of period |  | 1,559,012 |  |  | $ | 11.60 |  |  |  |  |
Exercised |  | (1,559,012) |  |  | $ | 11.60 |  |  |  |  |
Outstanding at end of period |  | — |  |  | $ | — |  |  |  |  |
Exercisable at end of period |  | — |  |  | $ | — |  |  |  |  |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration